首页 > 市场调查报告书 > 製药

2030 年欧洲痤疮药物市场预测 - 区域分析 - 按治疗类别、配方、类型、痤疮类型和配销通路

市场调查报告书

商品编码

1567804

2030 年欧洲痤疮药物市场预测 - 区域分析 - 按治疗类别、配方、类型、痤疮类型和配销通路

Europe Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel

出版日期: 2024年08月07日 | 出版商:

The Insight Partners | 英文 127 Pages | 订单完成后即时交付

价格

简介目录图表

2022年欧洲痤疮药物市场价值为19.6308亿美元，预计到2030年将达到31.1269亿美元；预计 2023 年至 2030 年复合年增长率为 6.0%。

基于尖端技术和数据驱动策略的个人化治疗方案推动欧洲痤疮药物市场

在欧洲痤疮药物市场中采用先进技术和数据驱动的方法开闢了新的研发途径。透过收集和分析患者资料，研究人员可以获得有关痤疮根本原因的宝贵见解，确定治疗反应的模式和趋势，并发现治疗干预的新潜在目标。这可以推动新型药物、创新治疗策略以及针对痤疮患者多样化需求的个人化护肤产品的开发。透过利用人工智慧 (AI)、机器学习演算法、基因检测和其他尖端工具，医疗保健提供者现在可以分析大量资料，以更好地了解患者独特的皮肤状况、遗传倾向、生活方式因素和治疗反应。这种个人化方法可以製定专门针对每个患者的个人需求而设计的客製化治疗计划。

2021 年 3 月，Thorne HealthTech 旗下健康情报公司 Onegevity 与全球顶级美容和个人护理产品製造商之一联合利华合作，推出更个人化的痤疮介入和治疗方法。此次科学合作旨在研究多组学或不同生物学学科整合的潜力，以实现更个人化的痤疮治疗方法。此次合作旨在创建新的诊断模型，利用 Onegevity 的人工智慧和机器学习功能来解锁客製化的痤疮治疗计划，从而评估影响个人健康的数十亿个生物特征。个人化治疗计划透过考虑患者的特定特征和可能影响其对痤疮药物反应的因素来帮助优化治疗效果。根据此类患者特定资料，医疗保健提供者可以开出更可能对该特定个体有效的治疗方法。这提高了成功治疗痤疮的机会，并减少了副作用和不良反应的可能性，从而改善了患者的治疗效果并提高了满意度。因此，整合先进技术和数据驱动的方法来设计个人化治疗计划，为欧洲痤疮药物市场的创新、成长和改善患者治疗结果创造了重大机会。

欧洲痤疮药物市场概况

欧洲在全球痤疮药物市场中排名第二。预计在预测期内将出现显着的复合年增长率。该地区痤疮药物市场的成长归因于痤疮盛行率的增加和主要参与者的不断增加。以研究为基础的製药业可以在支持欧洲痤疮药物市场成长并确保其未来在全球经济中的竞争力方面发挥关键作用。总部位于柏林的 Formel Skin 是皮肤科远距医疗领域的先驱，宣布于 2022 年 1 月完成了 32.35 (30) 万美元的系列融资。 Heartcore Capital 与Vorwerk Ventures。利用这笔资金，该公司计划对其远端护肤平台进行长期开发和扩展。

欧洲痤疮药物市场收入及 2030 年预测（百万美元）

欧洲痤疮药物市场细分

欧洲痤疮药物市场根据治疗类别、配方、类型、痤疮类型、配销通路和国家进行细分。

根据治疗类别，欧洲痤疮药物市场分为类维生素A、过氧化苯甲酰、抗生素、水杨酸等。 2022 年，类视黄醇细分市场占据最大份额。

从剂型来看，欧洲痤疮药物市场分为外用药物和口服药物。 2022 年，外用药物领域占据更大的份额。

按类型划分，欧洲痤疮药物市场分为处方药和非处方药。 2022 年，处方药领域占据更大的最大份额。

根据痤疮类型，欧洲痤疮药物市场分为非发炎性痤疮和发炎性痤疮。 2022 年，发炎性痤疮部分占据了更大的份额。

在配销通路方面，欧洲痤疮药物市场分为药局和药局、零售店和电子商务。 2022 年，药局和药局细分市场占据最大份额。

根据国家/地区，欧洲痤疮药物市场分为德国、法国、英国、义大利、西班牙和欧洲其他地区。 2022 年，德国在欧洲痤疮药物市场占据主导地位。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Almirall SA、强生公司、Bausch Health Companies Inc、Galderma SA、辉瑞公司、GSK Plc、Viatris Inc 和 Pierre Fabre SA 是欧洲痤疮药物领域的一些领先公司市场。

欧洲痤疮药物市场 - 主要市场动态
主要市场驱动因素
- 严重痤疮的盛行率不断增加
- 新药上市
主要市场限制
- 与痤疮药物相关的副作用
主要市场机会
- 基于尖端技术和数据驱动策略的个人化治疗方案
未来趋势
- 对有机和自然疗法的需求激增
驱动因素和限制的影响：

第 6 章：痤疮药物市场 - 欧洲市场分析

第 7 章：欧洲痤疮药物市场分析 - 按治疗类别

类维生素A
过氧化苯甲酰
抗生素
水杨酸
其他的

第 8 章：欧洲痤疮药物市场分析 - 按配方

外用药物
口服药物

第 9 章：欧洲痤疮药物市场分析 - 按类型

处方药
非处方药

第 10 章：欧洲痤疮药物市场分析 - 按痤疮类型

非发炎性痤疮
发炎性痤疮

第 11 章：欧洲痤疮药物市场分析 - 按配销通路

药局和药局
零售店
电子商务

第 12 章：欧洲痤疮药物市场 - 国家分析

欧洲
- 德国
- 法国
- 英国
- 义大利
- 西班牙
- 欧洲其他地区

第 13 章：痤疮药物市场-产业格局

概述
痤疮药物市场的成长策略
有机成长策略
- 概述
无机成长策略
- 概述
Farmapiel 提供的产品与其他公司痤疮产品的比较

第 14 章：公司简介

Teva Pharmaceutical Industries Ltd
Almirall SA
Johnson & Johnson
Sun Pharmaceutical Industries Ltd
Bausch Health Companies Inc
Galderma SA
Pfizer Inc
GSK Plc
Viatris Inc
Pierre Fabre SA

第 15 章：附录

简介目录图表

Product Code: BMIRE00030657

The Europe acne medication market was valued at US$ 1,963.08 million in 2022 and is expected to reach US$ 3,112.69 million by 2030; it is estimated to register at a CAGR of 6.0% from 2023 to 2030.

Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies Drive Europe Acne Medication Market

Adopting advanced technologies and data-driven approaches in the Europe acne medication market opens up new avenues for research and development. By collecting and analyzing patient data, researchers can gain valuable insights into the underlying causes of acne, identify patterns and trends in treatment responses, and discover new potential targets for therapeutic interventions. This can drive the development of novel medications, innovative treatment strategies, and more personalized skincare products tailored to the diverse needs of acne patients. By leveraging artificial intelligence (AI), machine learning algorithms, genetic testing, and other cutting-edge tools, healthcare providers can now analyze vast data to gain a better understanding of patient's unique skin conditions, genetic predispositions, lifestyle factors, and treatment responses. This personalized approach allows for the development of tailored treatment plans specifically designed to address each patient's individual needs.

In March 2021, Onegevity, a health intelligence firm and a subsidiary of Thorne HealthTech, teamed up with Unilever, one of the top manufacturers of beauty and personal care products worldwide, to enable a more personalized approach to acne intervention and treatment. The scientific collaboration is meant to investigate the potential of multi-omics, or the integration of different biological disciplines, to enable more individualized approaches to treating acne. The collaboration aims to create new diagnostic models that can unlock customized acne treatment plans by utilizing Onegevity's AI and machine learning capabilities that allow the evaluation of billions of biological characteristics affecting a person's health. Personalized treatment plans help to optimize treatment efficacy by taking into account patients' specific characteristics and factors that may influence their response to acne medication. Based on such patient-specific data, healthcare providers can prescribe treatments that are more likely to be effective for that particular individual. This improves the chances of successfully treating acne and reduces the likelihood of side effects and adverse reactions, leading to better patient outcomes and increased satisfaction. Thus, integrating advanced technologies and data-driven approaches for designing personalized treatment plans creates significant opportunities for innovation, growth, and improved patient outcomes in the Europe acne medication market.

Europe Acne Medication Market Overview

Europe ranks second in the global acne medication market. It is further anticipated to register a significant CAGR during the forecast period. The acne medication market growth in the region is ascribed to the increasing prevalence of acne and the growing presence of major players. The research-based pharmaceutical industry can play a key role in supporting the acne medication market growth in Europe and ensuring its future competitiveness in the global economy. Formel Skin, a Berlin-based business that is a pioneer in dermatology telehealth, announced the completion of a US$ 32.35 (30) million series fundraising round in January 2022. The funding was led by Singular and Heal Capital and supported by Cherry Ventures, Heartcore Capital, and Vorwerk Ventures. With this funding, the company plans to undertake the long-term development and expansion of its remote skincare platform.

Europe Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

Europe Acne Medication Market Segmentation

The Europe acne medication market is segmented based on therapeutic class, formulation, type, acne type, distribution channel, and country.

Based on therapeutic class, the Europe acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the Europe acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the Europe acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the Europe acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the Europe acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the Europe acne medication market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the Europe acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, and Pierre Fabre SA are some of the leading companies operating in the Europe acne medication market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Acne Medication Market Landscape

4.1 PEST Analysis
4.2 Pricing Analysis of Topical and Oral Medication
4.3 Patient Population Undergoing Acne Treatment

5. Europe Acne Medication Market - Key Market Dynamics

5.1 Europe Acne Medication Market - Key Market Dynamics
5.2 Key Market Drivers
- 5.2.1 Increasing Prevalence of Severe Acne
- 5.2.2 Launch of Novel Drugs
5.3 Key Market Restraints
- 5.3.1 Side Effects Associated with Acne Medication
5.4 Key Market Opportunities
- 5.4.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
5.5 Future Trends
- 5.5.1 Upsurge in Need for Organic and Natural Treatments
5.6 Impact of Drivers and Restraints:

6. Acne Medication Market - Europe Market Analysis

7. Europe Acne Medication Market Analysis - by Therapeutic Class

7.1 Retinoids
- 7.1.1 Overview
- 7.1.2 Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Benzoyl Peroxide
- 7.2.1 Overview
- 7.2.2 Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Antibiotics
- 7.3.1 Overview
- 7.3.2 Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Salicylic Acid
- 7.4.1 Overview
- 7.4.2 Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
- 7.5.1 Overview
- 7.5.2 Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Acne Medication Market Analysis - by Formulation

8.1 Topical Medication
- 8.1.1 Overview
- 8.1.2 Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Oral Medication
- 8.2.1 Overview
- 8.2.2 Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Acne Medication Market Analysis - by Type

9.1 Prescription Medicine
- 9.1.1 Overview
- 9.1.2 Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
9.2 Over-the-Counter Medicine
- 9.2.1 Overview
- 9.2.2 Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Acne Medication Market Analysis - by Acne Type

10.1 Non-Inflammatory Acne
- 10.1.1 Overview
- 10.1.2 Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
10.2 Inflammatory Acne
- 10.2.1 Overview
- 10.2.2 Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. Europe Acne Medication Market Analysis - by Distribution Channel

11.1 Pharmacies and Drug Stores
- 11.1.1 Overview
- 11.1.2 Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.2 Retail Stores
- 11.2.1 Overview
- 11.2.2 Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
11.3 E-Commerce
- 11.3.1 Overview
- 11.3.2 E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. Europe Acne Medication Market - Country Analysis

12.1 Europe
- 12.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.1 Europe: Acne Medication Market - Revenue and Forecast Analysis - by Country
  - 12.1.1.2 Germany
  - 12.1.1.3 Germany: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.3.1 Germany: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.3.2 Germany: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.3.3 Germany: Acne Medication Market Breakdown, by Type
    - 12.1.1.3.4 Germany: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.3.5 Germany: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.4 France
  - 12.1.1.5 France: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.5.1 France: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.5.2 France: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.5.3 France: Acne Medication Market Breakdown, by Type
    - 12.1.1.5.4 France: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.5.5 France: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.6 UK
  - 12.1.1.7 UK: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.7.1 UK: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.7.2 UK: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.7.3 UK: Acne Medication Market Breakdown, by Type
    - 12.1.1.7.4 UK: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.7.5 UK: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.8 Italy
  - 12.1.1.9 Italy: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.9.1 Italy: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.9.2 Italy: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.9.3 Italy: Acne Medication Market Breakdown, by Type
    - 12.1.1.9.4 Italy: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.9.5 Italy: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.10 Spain
  - 12.1.1.11 Spain: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.11.1 Spain: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.11.2 Spain: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.11.3 Spain: Acne Medication Market Breakdown, by Type
    - 12.1.1.11.4 Spain: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.11.5 Spain: Acne Medication Market Breakdown, by Distribution Channel
  - 12.1.1.12 Rest of Europe
  - 12.1.1.13 Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
    - 12.1.1.13.1 Rest of Europe: Acne Medication Market Breakdown, by Therapeutic Class
    - 12.1.1.13.2 Rest of Europe: Acne Medication Market Breakdown, by Formulation
    - 12.1.1.13.3 Rest of Europe: Acne Medication Market Breakdown, by Type
    - 12.1.1.13.4 Rest of Europe: Acne Medication Market Breakdown, by Acne Type
    - 12.1.1.13.5 Rest of Europe: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

13.1 Overview
13.2 Growth Strategies in Acne Medication Market
13.3 Organic Growth Strategies
- 13.3.1 Overview
13.4 Inorganic Growth Strategies
- 13.4.1 Overview
13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

14.1 Teva Pharmaceutical Industries Ltd
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Almirall SA
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Johnson & Johnson
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Sun Pharmaceutical Industries Ltd
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Bausch Health Companies Inc
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Galderma SA
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Pfizer Inc
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 GSK Plc
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Viatris Inc
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Pierre Fabre SA
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments

15. Appendix

15.1 About The Insight Partners
15.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. Europe Acne Medication Market Segmentation
Table 2. Topical Medication
Table 3. Oral Medication
Table 4. Patient Population undergoing Acne Treatment from 2020-2023
Table 5. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
Table 6. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
Table 7. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
Table 8. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
Table 9. Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
Table 10. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
Table 11. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 12. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 13. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 14. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 15. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 16. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 17. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 18. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 19. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 20. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 21. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 22. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 23. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 24. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 25. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 26. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 27. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 28. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 29. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 30. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 31. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 32. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 33. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 34. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 35. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 36. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
Table 37. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
Table 38. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
Table 39. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
Table 40. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
Table 41. Recent Organic Growth Strategies in Acne Medication Market
Table 42. Recent Inorganic Growth Strategies in the Acne Medication Market
Table 43. Glossary of Terms, Acne Medication Market

List Of Figures

Figure 1. Europe Acne Medication Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Acne Medication Market Revenue (US$ Million), 2022-2030
Figure 5. Europe Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
Figure 6. Retinoids: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Benzoyl Peroxide: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Antibiotics: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Salicylic Acid: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Europe Acne Medication Market Share (%) - by Formulation (2022 and 2030)
Figure 12. Topical Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Oral Medication: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Europe Acne Medication Market Share (%) - by Type (2022 and 2030)
Figure 15. Prescription Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Over-the-Counter Medicine: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Europe Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
Figure 18. Non-Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Inflammatory Acne: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Europe Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
Figure 21. Pharmacies and Drug Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Stores: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. E-Commerce: Europe Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 25. Europe: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 26. Germany: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. UK: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Italy: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Spain: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Rest of Europe: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
Figure 32. Growth Strategies in Acne Medication Market